Shouyao Holdings (Beijing) Co., LTD. (SHA:688197)

China · Delayed Price · Currency is CNY

32.42

-0.98 (-2.93%)

Sep 1, 2026, 4:00 PM EDT

-29.69% (1Y)

Market Cap	4.82B -29.7%
Revenue (ttm)	34.67M +1,518.4%
Net Income	-85.52M
EPS	-0.58
Shares Out	148.72M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	5,495,820
Open	33.11
Previous Close	33.40
Day's Range	32.20 - 35.36
52-Week Range	29.71 - 50.48
Beta	0.67
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 29, 2026

About SHA:688197

Shouyao Holdings (Beijing) Co., LTD. engages in the research, development, and production of drugs in China. The company offers drugs for oncology indications, including non-small cell lung cancer, lymphoma, hepatocellular carcinoma, pancreatic cancer, breast cancer, ovarian cancer, thyroid cancer, leukemia, and diabetes. The company was founded in 2016 and is headquartered in Beijing, China. [Read more]

Industry Biotechnology

Sector Healthcare

Founded 2016

Employees 172

Stock Exchange Shanghai Stock Exchange

Ticker Symbol 688197

Full Company Profile

Financial Performance

In 2025, SHA:688197's revenue was 8.67 million, an increase of 119.88% compared to the previous year's 3.94 million. Losses were -128.83 million, -39.21% less than in 2024.

Financial Statements